Healthcare - Biotechnology - NASDAQ - US
$ 0.0001
0 %
$ 4.46 K
Market Cap
0.0
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
49.37%
Net Income
Estimate
189.77%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aridis Pharmaceuticals, Inc.
ARDS has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ARDS
EBIT FORECAST
EBIT Forecast Chart ARDS
NET INCOME FORECAST
Net Income Chart ARDS